Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Linkesch

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Leukemia|April 16, 2004
RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implicationsH H Schmidt, S Strehl, D Thaler, et al.
Bone Marrow Transplantation|October 31, 2002
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantationN Worel, D Biener, P Kalhs, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patientsH T Greinix, W Linkesch, M Seifert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trialM A Fridrik, H Hausmaninger, W Linkesch, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin BJ L Harousseau, A W Dekker, A Stamatoullas-Bastard, et al.
Science (New York, N.Y.)|September 25, 2001
Roots of clinical resistance to STI-571 cancer therapyA Hochhaus, S Kreil, A Corbin, et al.
Leukemia|May 23, 2001
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphomaM Mitterbauer, P Neumeister, P Kalhs, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphomaM A Fridrik, G Jäger, H R Kienzer, et al.
Bone Marrow Transplantation|January 23, 1999
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemiaE Reiter, H T Greinix, S Brugger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variablesJ Beyer, A Kramar, R Mandanas, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Leukemia|April 16, 2004
RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implicationsH H Schmidt, S Strehl, D Thaler, et al.
Bone Marrow Transplantation|October 31, 2002
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantationN Worel, D Biener, P Kalhs, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patientsH T Greinix, W Linkesch, M Seifert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trialM A Fridrik, H Hausmaninger, W Linkesch, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin BJ L Harousseau, A W Dekker, A Stamatoullas-Bastard, et al.
Science (New York, N.Y.)|September 25, 2001
Roots of clinical resistance to STI-571 cancer therapyA Hochhaus, S Kreil, A Corbin, et al.
Leukemia|May 23, 2001
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphomaM Mitterbauer, P Neumeister, P Kalhs, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphomaM A Fridrik, G Jäger, H R Kienzer, et al.
Bone Marrow Transplantation|January 23, 1999
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemiaE Reiter, H T Greinix, S Brugger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variablesJ Beyer, A Kramar, R Mandanas, et al.
Pageof 15